Indivumed
Indivumed is a biotech company founded in 2002, dedicated to advancing precision oncology. They specialize in discovering novel therapeutic targets by leveraging a unique, patient-centric, data-driven R&D approach. Their core assets include a vast pre-analytically controlled tumor and normal tissue sample resource, a comprehensive multi-omics and clinical database (IndivuType), and advanced biomathematical tools including AI. Indivumed also develops patient-derived cellular models for target validation. The company aims to progress small and large molecules through the drug discovery and development pipeline towards IND and beyond, with a pipeline of novel targets in CRC. They foster innovation through global networks like Onco AI-Med and the Indivumed Global Clinical Network, collaborating with leading oncologists and cancer researchers worldwide. Indivumed's ultimate vision is a world where precision therapy offers a cure for every cancer patient.
Indivumed
Indivumed is a biotech company founded in 2002, dedicated to advancing precision oncology. They specialize in discovering novel therapeutic targets by leveraging a unique, patient-centric, data-driven R&D approach. Their core assets include a vast pre-analytically controlled tumor and normal tissue sample resource, a comprehensive multi-omics and clinical database (IndivuType), and advanced biomathematical tools including AI. Indivumed also develops patient-derived cellular models for target validation. The company aims to progress small and large molecules through the drug discovery and development pipeline towards IND and beyond, with a pipeline of novel targets in CRC. They foster innovation through global networks like Onco AI-Med and the Indivumed Global Clinical Network, collaborating with leading oncologists and cancer researchers worldwide. Indivumed's ultimate vision is a world where precision therapy offers a cure for every cancer patient.